1H and 13C HR-MAS spectroscopy of intact biopsy samples ex vivo and in vivo 1H MRS study of human high grade gliomas

NMR in Biomedicine

Volumn 17, Issue 4, 2004, Pages 191-205

  Martínez Bisbal, M Carmen ^a,b   Martí Bonmatí, Luis ^b   Piquer, José ^c   Revert, Antonio ^c   Ferrer, Pilar ^c   Llácer, José L ^c   Piotto, Martial ^d   Assemat, Olivier ^d   Celda, Bernardo ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c HOSPITAL DE LA RIBERA   (Spain)

^d Bruker Corporation   (United States)

Author keywords

Biopsy tissues; Brain tumours; Ex vivo MRS; HR MAS; In vivo MRS; PCA extracts

Indexed keywords

BIOPSY; HYDROGEN; METABOLITES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; TISSUE; TUMORS;

CHEMICAL EXTRACTS; HUMAN TISSUES;

BIOMEDICAL ENGINEERING;

DOCUSATE SODIUM; PERCHLORIC ACID; TISSUE EXTRACT; WATER; BIOLOGICAL MARKER; CARBON; PROTON; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BRAIN TUMOR; CANCER GRADING; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEGRADATION; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; METABOLIC PARAMETERS; METABOLITE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTRAL SENSITIVITY; TEMPERATURE; TUMOR BIOPSY; COMPARATIVE STUDY; EVALUATION; METABOLISM; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE; STATISTICS; VALIDATION STUDY;

ADULT; AGED; BIOLOGICAL MARKERS; BRAIN NEOPLASMS; CARBON ISOTOPES; FEMALE; GLIOBLASTOMA; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTONS; STATISTICS;

EID: 4143142007     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/nbm.888     Document Type: Article

References (42)

1. Polednak AP, Flannery JT. Brain, other central nervous system, and eye cancer. Cancer 1995; 75: 330-337.
2. Levin VA, Leibel SA, Gutin PH. Neoplasms of the central nervous system. In Cancer Principles and Practice of Oncology (Vol. 2, 5th edn), De Vita VT, Jr., Hellman S, Rosenberg SA (eds). Lippincott-Raven: Philadelphia, PA; 2022-2081.
3. Santos Ortega M, Reynés Muntaner G, Cerdá Nicolás M, Piquer Belloch J. Astrocitomas. In Tumores del Sistema Nervioso Central en el Adulto y en la Infancia (Chap. 18), Arraez MA, Herruzo I, Acha T, Benavides T (eds). Aula Médica: Madrid, 2003.
4. Martínez-Bisbal MC, Celda B, Martí-Bonmatí L, Casanova-Estruch B, Coret-Ferrer F. Diferencias en la espectroscopía de las lesiones de esclerosis múltiple remitente recurrente mediante resonancia magnética. Rev. Neurol. 2002; 34: 807-812.
5. 1H MRS study. J. Neurolo. 2003; 250: 22-28.
6. Kaminogo M, Ishimaru H, Morikawa M, Ochi M, Ushijima R, Tani M, Matsuo Y, Kawakubo J, Shibata S. Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localized proton spectroscopy of brain. Neuroradiology 2001; 43: 353-363.
7. Castillo M, Kwock L. Clinical applications of proton magnetic resonance spectroscopy in the evaluation of common intracranial tumours. Top. Magn. Reson. Imag. 1999; 10: 104-113.
8. Burtscher IM, Holtas S. Proton magnetic resonance spectroscopy in brain tumours: clinical applications. Neuroradiology. 2001; 43: 345-352.
9. Martínez-Bisbal MC, Celda B, Martí-Bonmatí L, Ferrer P, Revert AJ, Piquer J, Mollá E, Arana E, Dosdá R. Contribución de la espectroscopia de resonancia magnética a la clasificación del glioma de alto grado. Valor predictivo de las macromoléculas. Rev. Neurol. 2002; 34: 309-313.
10. 1H brain tumour spectra: a multicentre study. Magn. Reson. Med. 2003; 49: 29-36.
11. 1H MRS of high grade astrocytomas: mobile lipid accumulation in necrotic tissue. NMR Biomed. 1994; 7: 149-155.
12. 1H MR spectroscopy. NMR Biomed. 1994; 7: 172-180.
13. Chieng LL, Ma MJ, Becerra L, Ptak T, Tracey I, Lackner A, González RG. Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. Proc. Natl Acad. Sci. 1997; 94: 6408-6413.
14. Cheng LL, Chang LW, Louis DN, Gonzalez G. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. Cancer Res. 1998; 58: 1825-1832.
15. 1H HR-MAS spectroscopy of intact biopsy samples in vitro. MAGMA 1999; 8: 121-128.
16. Cheng LL, Anthony DC, Comité AR, Black PM, Tzika AA, Gonzalez G. Quantification of microheterogeneity in glioblastoma multiforme with ex vivo high-resolution magic-angle spinning (HRMAS) proton magnetic resonance spectroscopy. Neuro-Oncology 2000; 2: 87-95.
17. Pascual JM, Carceller F, Cerdán S, Roda JM. Diagnóstico diferencial de tumores cerebrales 'in vitro' por espectroscopía de resonancia magnética de protón. Método de los cocientes espectrales. Neurocirugía 1998; 9: 4-10.
18. 1H NMR spectra from perchloric acid extracts of human brain tumour biopsies. Magn. Reson. Med. 1998; 39: 869-877.
19. Bottomley PA. Selective volume method for performing localized NMR spectroscopy. US patent 4 480 228, 1994.
20. Spectroscopy Packages Gyroscan ACSNT R6. Philips Medical Systems: Amsterdam, 1998.
21. Sardina FJ, Cobas JC, Navarro A. MestRe-C 2.2. Departamento de Quimica Orgánica, Universidade de Santiago de Compostela, A Coruña, Spain, 2000.
22. XWIN-NMR 3.1. Bruker BioSpin GmbH, Software Department, Germany, 2001.
23. Goddard TD, Kneller DG. SPARKY 3. University of California: San Francisco, CA, 1999.
24. UpSol NMR Prediction version 1.1. Upstream Solutions GmbH: Switzerland, 1999.
25. Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed. 2000; 13: 129-153.
26. Sitter B, Sonnewald U, Spraul M, Fjösne HE, Gribbestad I. High-resolution magic angle spinning MRS of breast cancer tissue. NMR Biomed. 2002; 15: 327-337.
27. 13C chemical-shift data. J Biomol. NMR 1994; 4: 171-180.
28. Wüthrich K. NMR of amino acid residues and mononucleotides. In NMR of Proteins and Nucleic Acids, Chap. 2. Wiley: New York, 1986; 17.
29. Wüthrich K. Carbon-13 NMR of amino acids, peptides and proteins. In NMR in Biological Research: Peptides and Proteins, Chap. V. North-Holland: Amsterdam, 1976; 171-176.
30. García-Martín ML, García-Espinosa MA, Cerdán S. Biochemistry detectable by MRS. In l5th Annual Scientific Meeting of the European Society for Magnetic Resonance in Medicine and Biology (ESMRMB), Geneva, Switzerland, 1998.
31. Fan WMT. Metabolite profiling by one- and two-dimensional NMR analysis of complex mixtures. Prog. Nucl. Magn. Reson. 1996; 28: 161-219.
32. 13C NMR spectroscopy of human blood plasma. Anal. Chem. 1995; 67: 793-811.
33. 1H-NMR spectroscopy of human cerebrospinal fluid: effects of sample manipulation and assignment of resonances. J. Pharm. Biomed. 1993; 11: 651-664.
34. Sitter B, Sonnewald U, Spraul M, Fjösne HE, Gribbestad IS. High-resolution magic angle spinning MRS of breast cancer tissue. NMR Biomed. 2002; 15: 327-337.
35. Celda B, Montelione G. Total correlation spectroscopy (TOCSY) of proteins using co-addition of spectra recorded with several mixing times. J. Magn. Reson. 1993; B101: 189-219.
36. 1H MR spectroscopy imaging. NMR Biomed. 2003; 16: 12-18.
37. Danielsen ER, Ross B. Hyperglycinemia. In Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases. Marcel Dekker: New York, 1998; 259-263.
38. Mader I, Roser W, Hagberg G, Schneider M, Sauter R, Seelig J, Radue EW, Steinbrich W. Proton chemical shift imaging, metabolic maps, and single voxel spectroscopy of glial brain tumors. MAGMA 1996; 4: 139-150.
39. 1H MR spectroscopy-initial results. Radiology 1999; 213: 785-793.
40. Castillo M, Smith JK, Kwock L. Correlation of myo-Inositol levels and grading of cerebral astrocytomas. Am. J. Neuroradiol. 2000; 21: 1645-1649.
41. Danielsen ER, Ross B. Basic physics of MRS. In Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases. Marcel Dekker: New York, 1998; 5-22.
42. de Graaf RA. In vivo NMR spectroscopy. In In vivo NMR Spectroscopy. Principles and Techniques. Wiley: Chichester, 1998; 41-140.